Dr. Michael Murphy, PhD

Director, Research at Celldex Therapeutics

Speaker

Michael Murphy is a Research Director at Celldex Therapeutics, a clinical-stage biotech developing innovative antibody therapeutics targeting mast cells. In this role, he leads a research team which utilizes innovative approaches to help advance Celldex’s early-stage pipeline. He earned his PhD in Genetics and Genomics from the University of Connecticut, followed by a Postdoctoral Fellowship at the University of Connecticut School of Medicine with a focus in immunology and autoimmune disease.